PPT-Cardiogenic Shock Where Do We Go After The SHOCK Trial

Author : mia | Published Date : 2023-08-30

William W ONeill MD Henry Ford Health System Medical Director Center for Structural Heart Disease Detroit MI Diffuse Multivessel Disease Border Zone Dysfunction

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Cardiogenic Shock Where Do We Go After T..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Cardiogenic Shock Where Do We Go After The SHOCK Trial: Transcript


William W ONeill MD Henry Ford Health System Medical Director Center for Structural Heart Disease Detroit MI Diffuse Multivessel Disease Border Zone Dysfunction Central Zone Dyskinesis. sarah. Shock. Learning Outcomes. Define shock. List the categories of shock. Explain the physiological consequences of shock. Compare physiological short-term and long-term control of blood pressure. Technology. Emergent Support. Clinical . Evidence and . Investigations. The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: . Results from the USpella Registry. Ananya Anne. Case . 64 y/o man with . pmh. of CHF, COPD, IDDM2, is sent from his nursing home with altered mental status. On presentation he is AAOX1 and follows some commands. His vitals are stable except for O2 sat which is 88%. On physical exam, there are some fine crackles to auscultation in the posterior lung fields. He has 1+ pitting edema in the lower extremities. JVP is not appreciable. His echocardiogram from one month prior shows an EF ~45%. His EKG is unchanged with no acute changes. . Hypotention. /shock. Reza . ghaderi. DR. 1393-spring . Definition. Shock is a physiologic state characterized by a significant reduction of systemic tissue perfusion, resulting in decreased oxygen delivery to the tissues.. Types of Shock. Hypovolemic. Inadequate blood volume. Distributive. Inappropriately distributed blood volume and flow. Cardiogenic. Insufficient CO caused by poor myocardial function. Obstructive. Obstructed flow (into or out of the heart). “a loss of a sense of security when encountering the unfamiliar at every turn”. What differences do you expect to encounter? . Physical . -. Social . -. Worldview: values, assumptions, goals . Rutgers Complex Health and Illness. Learning Outcomes. By the end of the class, the student will be able to:. Apply the concepts of shock pathophysiology and management to the care of patients with hypovolemic, cardiogenic and septic shock using a case study approach. . Site Initiation Visit. Version 7.0 02 August 2019. Chief Investigator: Dr Tony . Whitehouse. Funder: NIHR . Efficacy and Mechanism Evaluation . (. EME) programme. 401 RBCCV 44205-1487 DOI: 10.5935/1678-9741.20130061 Ventricular assist device implantation with CentriMag VAS ® for biventricular mechanical support Assistência ventricular com implante do dispo DEPT OF PATHOLOGY AND MICROBIOLOGY . SKHMC. what is shock ?. Is a . final common pathway . for a number of serious or . potentially lethal clinical events- . e g. severe hemorrhage,. Extensive trauma or burns. Ruth Fisher, MBA. Henry Ford Health System. Vice President . Heart and Vascular Services. Detroit, MI. Detroit. C. ardiogenic. S. hock. I. nitiative. Detroit. . CSI. What is Detroit CSI. How did we start. Shock:. What Are the . Hemodynamics. ?. Jeff Davis, RRT, RCIS . Jeff Davis has nothing to disclose. Disclosures. Shock. Hippocrates perhaps first to describe shock . French surgeon Henri Francois Le . A.L. Mohammed Kareem . 2. 2020-2021. Definition: . Shock is a life-threatening condition that occurs when the body is not getting enough blood . flow(. hypoprefusion. ). . Lack of blood flow means the cells and organs do not get enough oxygen and nutrients to function properly. Many organs can be damaged as a result. Shock requires immediate treatment and can get worse very rapidly. As many 1 in 5 people who suffer shock will die . George W. Vetrovec, MD, MACC, MSCAI. Professor Emeritus, VCU Pauley Heart Center. Virginia Commonwealth University. Richmond, Virginia . USA. Disclosures:. Consultant: Abiomed, Merck, FDA. What Hemodynamic Support is Available?.

Download Document

Here is the link to download the presentation.
"Cardiogenic Shock Where Do We Go After The SHOCK Trial"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents